Stephen Bardin

Insider Reports History

Entity
Individual
Location
C/O Atai Life Sciences N.V., Krausenstrasse 9 10, Berlin, Germany
Signature
/s/ John Dunn, Esq., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Bardin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CalciMedica, Inc. Chief Financial Officer Common Stock 40K $150K $3.75 Nov 13, 2024 Direct
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 600K Mar 14, 2023 Direct
ATAI Life Sciences N.V. Chief Financial Officer Restricted Stock Unit 350K Mar 14, 2023 Direct

Insider Reports Filed by Stephen Bardin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CALC CalciMedica, Inc. Nov 13, 2024 0 $0 3 Nov 15, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Mar 14, 2023 2 $0 4 Mar 16, 2023 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Aug 16, 2022 0 $0 3 Aug 17, 2022 Chief Financial Officer